On January 24, Nanjing Children’s Hospital successfully performed Jiangsu’s first single-port robotic-assisted laparoscopic high ligation of the internal spermatic vein, marking a new era of ultra-minimally invasive pediatric surgery at the hospital.
The patient, a 13-year-old boy, was diagnosed with left-sided varicocele after noticing a worm-like mass in his scrotum, which worsened over time and threatened testicular development. Varicocele is a common vascular condition that can impair testicular function and fertility.
Under the expert leadership of Dr. Yunfei Guo, the urology team utilized the SHURUI® single-port surgical system, which offers a 10x magnified view and flexible snake-like instruments. This enabled precise ligation of the internal spermatic vein while preserving arteries and lymphatic vessels, significantly reducing the risk of postoperative complications like testicular atrophy and hydrocele.
Supported by a multidisciplinary team, the procedure was completed smoothly with minimal trauma and blood loss, providing a safer and more effective treatment option for pediatric patients. This milestone represents a major advancement for pediatric surgery at Nanjing Children’s Hospital and across Jiangsu province.
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.